
Healthcare Trends and Market Dynamics
We invite you to explore our firm’s perspective on the major developments shaping the world of healthcare and the industry leaders orchestrating those transformations. We share firsthand accounts from the entrepreneurs driving these advancements, showcasing their successes and challenges.
In addition to these real-world narratives, our research analysts are fully immersed in identifying the major trends and technological innovations that are driving change across the healthcare spectrum. Our detailed reports break down the complexities of these developments, aiding clients to pinpoint strategic investment opportunities.
Featured Podcasts
Listen in to conversations with industry leaders and innovators that are transforming the future of Healthcare

Managing Director of Pharmagellan and Professor of the Practice at Tufts University, Frank S. David, MD, PhD
Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics interviews Frank S. David, MD, PhD, Managing Director of Pharmagellan and Professor of the Practice at Tufts University. The healthcare investing and development world and the pharmacoeconomics world have historically operated separately despite drug pricing being core to both worlds. In this episode, Mel and Frank contrast how models are used and built in their respective worlds of pharmacoeconomics and healthcare investing and development.

Featured Research
Explore exclusive insights from our research team that are driving investment opportunities for discerning investors
Recent Articles
Read commentary and analysis from across Leerink Partners on markets, investing, and the Healthcare sector